Showing results (51-60 of 6,758) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|September 18, 2001
Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a reviewK M Truong, K Amankwa, S KucukarslanClinical Therapeutics|September 18, 2001
Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunctionG M Ferron, R A Preston, R J Noveck, et al.Clinical Therapeutics|September 18, 2001
Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertensionJ M Flack, E Saunders, A Gradman, et al.Clinical Therapeutics|September 18, 2001
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge modelD L Spangler, G Bensch, G J BerdyClinical Therapeutics|September 18, 2001
A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgeryX L Zhu, W K Wong, W M Yeung, et al.Clinical Therapeutics|March 15, 2003
Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled studyJ Luis Bautista, Christine Bugos, George Dirnberger, et al.Clinical Therapeutics|March 15, 2003
An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccineRobert T Schoen, Terry Deshefy-Longhi, Christian Van-Hoecke, et al.Clinical Therapeutics|March 15, 2003
Open-label, sequential comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary interventionMarc J Schweiger, Hameem U Changezi, Deborah Naglieri-Prescod, et al.Clinical Therapeutics|March 15, 2003
Approaches to pharmacy benefit management and the impact of consumer cost sharingBridget M OlsonClinical Therapeutics|March 15, 2003
Physician gender and changes in drug prescribing after the implementation of reference pricing in British ColumbiaMargreet S Duetz, Sebastian Schneeweiss, Malcolm Maclure, et al.Pageof 676